Vyriad Patents – Insights & Stats (Updated 2023)

Vyriad has a total of 25 patents globally, out of which none have been granted. Of these 25 patents, more than 88% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Vyriad.

Vyriad was founded in 2015. Vyriad is developing the next generation of targeted genetic therapeutics by engineering viruses, viral vectors, and viral envelope glycoproteins to deliver genes directly to specified cells. Oncolytic virotherapy, in vivo gene treatments, and gene editing applications are made easier by this targeted approach.

Do read about some of the most popular patents of Vyriad which have been covered by us in this article and also you can find Vyriad patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vyriad patent portfolio.

How many patents does Vyriad have?

Vyriad has a total of 25 patents globally. These patents belong to 5 unique patent families. Out of 25 patents, 22 patents are active.

How Many Patents did Vyriad File Every Year?

Vyriad Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVyriad Applications FiledVyriad Patents Granted
20232
20221
202114
20207
20191

How many Vyriad patents are Alive/Dead?

Worldwide Patents

Vyriad Patent Portfolio

How Many Patents did Vyriad File in Different Countries?

Vyriad Worldwide Patent Filing

Countries in which Vyriad Filed Patents

CountryPatent
Canada3
United States Of America3
New Zealand2
Mexico2
Israel2
Europe2
Australia2
Japan1
Singapore1
Hong Kong (S.A.R.)1
South Africa1
India1

Where are Research Centers of Vyriad Patents Located?

The Research Center of Vyriad is in the United States of America.

List of Vyriad patents

Vyriad PatentsTitle
US20230184765A1Detection Assays For Coronavirus Neutralizing Antibodies
US20230149536A1Compositions For Treating And/Or Preventing Coronavirus Infections
US20220178910A1Ifnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
EP4136457A1Detection Assays For Coronavirus Neutralizing Antibodies
EP3946421A4Ifnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
WO2023159102A1Combinations Of Checkpoint Inhibitors And Oncolytic Virus For Treating Cancer
CA3180508A1Detection Assays For Coronavirus Neutralizing Antibodies
CA3134957A1Ifn.Beta. As A Pharmacodynamic Marker In Vsv-Ifn.Beta.-Nis Oncolytic Therapy
CA3104509A1Methods Of Treating Cancer Using Combination Therapy
AU2021256894A1Detection Assays For Coronavirus Neutralizing Antibodies
AU2020244878A1Ifn-Β As A Pharmacodynamic Marker In Vsv-Ifn-Β-Nis Oncolytic Therapy
JP2023524200ADetection Assay For Coronavirus Neutralizing Antibodies
IL297237ADetection Assays For Coronavirus Neutralizing Antibodies
IL286724AIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
SG11202110697UAIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
HK40088918ADetection Assays For Coronavirus Neutralizing Antibodies
MX2022013030ADetection Assays For Coronavirus Neutralizing Antibodies
IN202117045835AIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
MX2021011748AIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy.
ZA202107708AIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
NZ793042ADetection Assays For Coronavirus Neutralizing Antibodies
NZ780590AIfnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy
WO2021212096A1Detection Assays For Coronavirus Neutralizing Antibodies
WO2021212101A1Compositions For Treating And/Or Preventing Coronavirus Infections
WO2020198652A1Ifnbeta As A Pharmacodynamic Marker In Vsv-Ifnbeta-Nis Oncolytic Therapy

What are Vyriad key innovation segments?

What Technologies are Covered by Vyriad?

The chart below distributes patents filed by Vyriad in different countries on the basis of the technology protected in patents. It also represents the markets where Vyriad thinks it’s important to protect particular technology inventions.

R&D Focus: How has Vyriad search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Vyriad?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.